-

Xevant Enhances Automated Analytics Platform with AI to Revolutionize Healthcare Data Ingestion and Standardization

Xevant’s new AI-powered capabilities streamline data ingestion and pave the way for transformative improvements in pharmacy cost management for PBM stakeholders.

LEHI, Utah--(BUSINESS WIRE)--Xevant, a leader in automated analytics for the pharmacy benefits industry, today announced the launch of new AI-powered capabilities designed to revolutionize the ingestion and standardization of healthcare data. These advancements address one of the most significant challenges faced by pharmacy benefit managers (PBMs), health plans, consultants, and employers—managing the influx of diverse, complex data formats quickly and efficiently.

Key Features:

  • Xevant’s new AI-powered platform automates the ingestion and analysis of data from multiple sources, eliminating manual processes and reducing time spent on data integration by as much as 65 percent.
  • The AI solution autonomously identifies and standardizes data from disparate formats into a consistent, usable structure, allowing PBM stakeholders to achieve real-time decision-making.
  • Through reinforcement learning, the system continuously improves by learning from human adjustments, ensuring greater accuracy and efficiency with every interaction.

“With the integration of AI, Xevant is addressing one of the most critical barriers to streamlined pharmacy benefit management,” said Brandon Newman, CEO of Xevant. “Our AI not only speeds up data ingestion and analysis, but it also empowers PBM stakeholders to make informed decisions faster and more efficiently than ever before.”

Pharmacy benefit management relies on vast amounts of data from multiple sources, all formatted differently. Traditionally, the process of standardizing this data for meaningful analysis has been time-intensive, slowing down decision-making. Xevant’s AI-driven approach tackles this issue head-on by autonomously transforming data from various formats into a consistent structure at scale. This innovation provides PBM stakeholders with immediate, actionable insights, enabling them to make faster, data-driven decisions that directly affect cost management and patient care quality.

The platform’s AI capabilities with reinforcement learning, position Xevant as a forward-thinking leader in healthcare data analytics. By reducing the manual burden on PBM stakeholders and streamlining complex data processes, Xevant’s solution not only improves pharmacy benefit management but also enhances patient outcomes by allowing quicker, more accurate decision-making.

Xevant’s continued investment in AI will further extend these capabilities, helping more clients achieve the lowest net costs faster while optimizing pharmacy benefits and improving affordability. These improvements pave the way for a significant shift in managing data across the healthcare industry.

About Xevant

Xevant is an industry leader in pharmacy benefits analytics and automation. By combining advanced data integration technologies and real-time insights, Xevant enables pharmacy benefit managers (PBMs), health plans, and consultants to deliver cost savings, optimize pharmacy benefit programs, and improve patient care.

Contacts

Media Contact:
Cassaundra Kalba
xevant@society22pr.com

Xevant


Release Versions

Contacts

Media Contact:
Cassaundra Kalba
xevant@society22pr.com

More News From Xevant

Xevant Unveils 2025 Drug Price Inflation White Paper: A Data-Driven Look at Rising Pharmaceutical Costs and Future Implications

LEHI, Utah--(BUSINESS WIRE)--Xevant, a leading provider of real-time data analytics for pharmacy benefit management, today announced the release of its 2025 Drug Price Inflation White Paper, providing key insights into the ongoing surge in pharmaceutical prices and what it means for payers, employers, and pharmacy benefit managers (PBMs). As the cost of healthcare continues to escalate, the new year has brought a fresh wave of price hikes across the pharmaceutical landscape. Within the first tw...

Xevant Introduces the All-New Biosimilar Dashboard, A Real-Time Analytics Tool to Accelerate Biosimilar Adoption and Reduce Unnecessary Biologic Drug Spend

LEHI, Utah--(BUSINESS WIRE)--Xevant, a leader in pharmacy benefits automation, today announces the launch of its all-new Biosimilar Dashboard, a real-time analytics tool designed to streamline biosimilar adoption and reduce unnecessary spending on biologic drugs. The Biosimilar Dashboard empowers health plans, employers, pharmacy benefit managers (PBMs), consultants, and benefits advisors by transforming fragmented prescription data into timely, actionable insights. This enhanced visibility ena...

Xevant Announces New E-Book: Navigating Obesity Care and GLP-1 Coverage: A Guide for Employers

LEHI, Utah--(BUSINESS WIRE)--As obesity rates in the United States have reached 41.9 percent among adults, Xevant has released a new e-book, Navigating Obesity Care and GLP-1 Coverage: A Guide for Employers, designed to empower employers with the tools and insights needed to address this critical health and economic challenge. The e-book offers actionable guidance on crafting effective, sustainable corporate weight management programs that drive meaningful results for both employees and employe...
Back to Newsroom